Meir Bialer

Hadassah Medical Center Mt. Scopus
Jerusalem, JM, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 99 publications

Progress report on new epilepsy treatments: A summary of the Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVIII). I. Treatments in preclinical and early clinical development.

Progress report on new epilepsy treatments: A summary of the Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVIII). I. Treatments in preclinical and early clinical development.

Journal: Epilepsia

Published: May 07, 2026

Progress report on new epilepsy treatments: A summary of the Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVIII). II. Treatments in more advanced clinical development.

Progress report on new epilepsy treatments: A summary of the Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVIII). II. Treatments in more advanced clinical development.

Journal: Epilepsia

Published: May 07, 2026

Antiseizure potency and neurotoxicity of the enantiomers of fenfluramine and norfenfluramine in rats and correlations with their concentrations in plasma and brain.

Antiseizure potency and neurotoxicity of the enantiomers of fenfluramine and norfenfluramine in rats and correlations with their concentrations in plasma and brain.

Journal: Epilepsia

Published: April 24, 2026

The Effect of Dicloxacillin Administration on Pharmacokinetics of Narrow Therapeutic Window Drugs: Phenytoin and Warfarin.

The Effect of Dicloxacillin Administration on Pharmacokinetics of Narrow Therapeutic Window Drugs: Phenytoin and Warfarin.

Journal: Clinical pharmacology and therapeutics

Published: April 14, 2026

Comparison of CYP2C9 activity between Ethiopian and non-Ethiopian Jews: an interethnic study of (S)-warfarin pharmacokinetic and pharmacodynamic.

Comparison of CYP2C9 activity between Ethiopian and non-Ethiopian Jews: an interethnic study of (S)-warfarin pharmacokinetic and pharmacodynamic.

Journal: Frontiers in pharmacology

Published: March 23, 2026

Utilization of Apixaban Pharmacokinetics for Dose Optimization in High-Risk Elderly Patients.

Utilization of Apixaban Pharmacokinetics for Dose Optimization in High-Risk Elderly Patients.

Journal: Clinical pharmacokinetics

Published: December 10, 2025

Antiseizure Medications that Did Not Reach the Epilepsy Market: An Assessment of Factors Contributing to Their Failed Clinical Development Over the Last Three Decades.

Antiseizure Medications that Did Not Reach the Epilepsy Market: An Assessment of Factors Contributing to Their Failed Clinical Development Over the Last Three Decades.

Journal: Drugs

Published: November 26, 2025

Enantioselective comparative analysis of the anticonvulsant potency of fenfluramine and norfenfluramine in mice.

Enantioselective comparative analysis of the anticonvulsant potency of fenfluramine and norfenfluramine in mice.

Journal: Epilepsia

Published: April 30, 2025

Folate transfer in placental choriocarcinoma cells treated with valproic acid: Insights gained through comparisons with the amide derivative sec-butylpropylacetamide and its individual stereoisomers.

Folate transfer in placental choriocarcinoma cells treated with valproic acid: Insights gained through comparisons with the amide derivative sec-butylpropylacetamide and its individual stereoisomers.

Journal: Epilepsia

Published: January 20, 2025

From barbiturates to ganaxolone: The importance of chirality in drug development and in understanding the actions of old and new antiseizure medications.

From barbiturates to ganaxolone: The importance of chirality in drug development and in understanding the actions of old and new antiseizure medications.

Journal: Pharmacology & therapeutics

Published: August 28, 2024

Progress report on new medications for seizures and epilepsy: A summary of the 17th Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII). I. Drugs in preclinical and early clinical development.

Progress report on new medications for seizures and epilepsy: A summary of the 17th Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII). I. Drugs in preclinical and early clinical development.

Journal: Epilepsia

Published: May 16, 2024

Progress report on new medications for seizures and epilepsy: A summary of the 17th Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII). II. Drugs in more advanced clinical development.

Progress report on new medications for seizures and epilepsy: A summary of the 17th Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII). II. Drugs in more advanced clinical development.

Journal: Epilepsia

Published: May 16, 2024

Showing 1-12 of 99

Last Updated: 09/26/2026